Fig. 6From: DDX3, a potential target for cancer treatmentDDX3 inhibitor RK-33. a. Structure of 5:7:5 tricyclic heterocycle RK-33. b. Graphic depiction of the interaction of DDX3 and RK-33 and the subsequent biological effectBack to article page